Skip to main content
Equibles

Verition Fund Management LLC

Position in ABVX — Abivax S.A.

CIK 1454027 GREENWICH, CT
Back to ABVX Full portfolio

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,097,708
+$11,208,399 QoQ
Shares Held
105,791
+307.7% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026
CallValue
$6,929,520
CallShares
52,000
PutValue
$8,528,640
PutShares
64,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $156,064,619 across 64 Biotechnology names. ABVX ranks #3 (9.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 438,746 $30,997,404
2
159,256 $21,138,048
3 ABVX
Abivax S.A.
This page 		105,791 $14,097,708
4 IDYA
IDEAYA Biosciences, Inc.
 184,054 $6,859,692
5 SNDX
Syndax Pharmaceuticals Inc
 304,939 $6,665,966
6 MRVI
Maravai Lifesciences Holdings, Inc.
 777,738 $4,853,085
7 CYTK
Cytokinetics Inc
 54,889 $4,675,993
8 RPRX
Royalty Pharma plc
 75,000 $4,205,250

All Filings in ABVX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,929,520 52,000
2026-06-30 $8,528,640 64,000
2026-06-30 $14,097,708 105,791
2026-03-31 $579,020 5,200
2026-03-31 $2,889,309 25,948
2025-12-31 $8,268,904 61,317
2025-09-30 $4,806,868 56,618